These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 769527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE, Tolagen K.
    Am J Med; 1976 May 31; 60(6):891-6. PubMed ID: 14504
    [Abstract] [Full Text] [Related]

  • 4. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI, Kloppenborg PW, Festen J, van't Laar A, Benraad TJ.
    Am J Cardiol; 1975 Oct 31; 36(5):716-21. PubMed ID: 1103606
    [Abstract] [Full Text] [Related]

  • 5. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA, Mansfield H, Miles K.
    N Z Med J; 1977 Sep 14; 86(595):216-9. PubMed ID: 343004
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 7. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec 01; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
    Hollifield JW.
    South Med J; 1976 Aug 01; 69(8):1034-6. PubMed ID: 785608
    [Abstract] [Full Text] [Related]

  • 12. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F, Braun B, Klaus D, Lemke R, Zehner J, Zöfel P.
    Dtsch Med Wochenschr; 1975 Mar 21; 100(12):577-84. PubMed ID: 1168122
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension.
    Golub MS, Tuck ML, Fittingoff DB.
    Clin Sci (Lond); 1981 Jul 21; 61(1):107-10. PubMed ID: 6265141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Propranolol, renin and hypertension: a review.
    Laragh JH, Bühler FR.
    Postgrad Med J; 1976 Jul 21; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [Abstract] [Full Text] [Related]

  • 18. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
    Sambhi MP, Eggena P, Barrett JD, Thananopavarn C, Tuck M, Wiedman C.
    J Clin Pharmacol; 1977 Apr 24; 17(4):214-24. PubMed ID: 849995
    [Abstract] [Full Text] [Related]

  • 20. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
    Thomas GW, Ledingham JG, Beilin LJ, Yeates KM.
    Aust N Z J Med; 1976 Aug 24; 6(3 Suppl):44-8. PubMed ID: 798576
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.